TY - JOUR
T1 - Worldwide experience with lymphatic mapping for invasive breast cancer
AU - Pendas, Solange
AU - Giuliano, Rosemary
AU - Swor, Gray
AU - Gardner, Mary
AU - Jakub, James
AU - Reintgen, Douglas S.
PY - 2004/6
Y1 - 2004/6
N2 - Lymphatic mapping and sentinel lymph node (SLN) biopsy have changed the standard of surgical care for women with invasive breast cancer. The rate of successful axillary SLN identification varies from 90% to 99%. Recurrence rates after a negative SLN biopsy have been remarkably low. Internal mammary node drainage has been noted in 8% to 22% of cases, but whether to harvest these extra-axillary sites of drainage remains controversial. Because of the low morbidity associated with the lymphatic mapping procedure, all women with invasive breast cancer should be considered as candidates for this more accurate staging technique.
AB - Lymphatic mapping and sentinel lymph node (SLN) biopsy have changed the standard of surgical care for women with invasive breast cancer. The rate of successful axillary SLN identification varies from 90% to 99%. Recurrence rates after a negative SLN biopsy have been remarkably low. Internal mammary node drainage has been noted in 8% to 22% of cases, but whether to harvest these extra-axillary sites of drainage remains controversial. Because of the low morbidity associated with the lymphatic mapping procedure, all women with invasive breast cancer should be considered as candidates for this more accurate staging technique.
UR - http://www.scopus.com/inward/record.url?scp=3042716060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042716060&partnerID=8YFLogxK
U2 - 10.1053/j.seminoncol.2004.03.013
DO - 10.1053/j.seminoncol.2004.03.013
M3 - Article
C2 - 15190488
AN - SCOPUS:3042716060
SN - 0093-7754
VL - 31
SP - 318
EP - 323
JO - Seminars in oncology
JF - Seminars in oncology
IS - 3
ER -